Developer docs
API playgroundTry for free, no card

Search company profiles

UNC Lineberger

Full company profile

uuid00093b1

Namestring
UNC Lineberger
Legal namestring
UNC Lineberger Comprehensive Cancer Center
Company typeenum
Private
Founded yearint
1972
Descriptiontext

UNC Lineberger Comprehensive Cancer Center, founded in 1972, is North Carolina's only public NCI-designated comprehensive cancer center, operating as an integral component of the University of North Carolina at Chapel Hill School of Medicine and affiliated with UNC Health. It functions as a research, clinical care, and training institution serving cancer patients, researchers, and communities across North Carolina. Its service portfolio spans eight research programs, three Centers of Excellence (bladder, endometrial, pancreatic cancer), and more than 20 center initiatives. Funding flows predominantly from the NCI Cancer Center Support Grant (P30 CA016086), the state-funded University Cancer Research Fund, NIH training grants, and sponsored research agreements; revenue from clinical trial management and core facility fee-for-service represents a secondary stream.

Its core technology and service infrastructure comprises shared resources organized into Animal Models, Basic Sciences, Clinical/Translational, Genomics/Proteomics, Population Sciences, and Research Support cores. Key facilities include the Translational Genomics Lab (high-throughput nucleic acid extraction, NGS library preparation, and sequencing at 20,000+ sample scale), the Tissue Culture Facility (400+ cell line repository), Rapid Case Ascertainment (statewide NC Cancer Registry interface supporting 900+ publications), and the MaTRIC project management platform launched in 2022 for population science research. Proprietary assets include the UNCseq targeted DNA sequencing panel and electronic patient-reported outcomes tools integrated into Epic EHR systems and used in global clinical trials. The center's clinical research infrastructure is operationalized through the Clinical Trials Office supporting investigator-initiated and industry-sponsored trials across breast, lung, prostate, sarcoma, and other oncology indications.

Its go-to-market model is sales-led via clinical referrals and community outreach, complemented by academic convening functions. Patient care is delivered through UNC Health facilities across North Carolina, extended statewide through the UNC Lineberger Cancer Network (telemedicine and community physician partnerships). Research services are sold fee-for-service to UNC investigators (subsidized) and external clients, while genomic and bioinformatic tools scale nationally via Epic integration and the OncoPRO initiative (with ASCO and the American Cancer Society) across 20+ health systems. Customer segments are hybrid: cancer patients (clinical care), academic and clinician-scientists (shared resources, training), referring physicians and health systems (specialty referrals and tool adoption), and rural/underserved NC communities (screening and outreach partnerships with organizations such as Kintegra Health and Raleigh Housing Authority).

Short descriptiontext

UNC Lineberger Comprehensive Cancer Center is North Carolina's only public NCI-designated comprehensive cancer center, conducting translational genomics, clinical trials, population science, and community outreach research while delivering cancer care through UNC Health and serving patients, researchers, and communities statewide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersChapel Hill, United States
HQ citystring
Chapel Hill
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cancer research, clinical oncology, translational research, clinical trials, genomic sequencing
Industry4 codes
1Oncology & Cancer Specialty Hospitals
CodeHLAFAHACPrimaryYes
2Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
CodeHLAFABAIPrimaryNo
3Central Laboratory Services (Core Lab Operations)
CodeHLAGAEAAPrimaryNo
4Surgical Oncology
CodeHLAKAFAGPrimaryNo
NAICS code3 codes
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
  • Diagnostic Imaging Centers621512
  • Colleges, Universities, and Professional Schools611310
SIC code3 codes
  • Services-Medical Laboratories8071
  • Services-Health Services8000
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Cancer Research and Treatment
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Government Research Grants and NCI Funding
TypeSubscription Recurring
Description

UNC Lineberger is an NCI-designated comprehensive cancer center supported by NCI Cancer Center Support Grant P30 CA016086, NIH-funded training grants (T32), and other peer-reviewed cancer-focused research grants. Membership is subject to NCI review and is largely provided to investigators holding NCI or other NIH funding.

unclineberger.org
2University Cancer Research Fund (UCRF)
TypeSubscription Recurring
Description

State-funded cancer research investment created by the N.C. General Assembly in 2007. Began with $25 million in 2007 and grew to $59.5 million by 2022. Funds discovery, innovation, and delivery of improved cancer care across North Carolina.

unclineberger.org
3Clinical Trial Revenue
TypeTransaction Fee
Description

UNC Lineberger's Clinical Trials Office turns research concepts into operational clinical trials, supporting investigator-initiated and industry-sponsored trials. Revenue is generated through clinical research management services, per-trial accruals, and industry sponsorship agreements.

unclineberger.org
4Shared Resource Service Fees
TypeTransaction Fee
Description

Core facilities (Tissue Culture, Translational Genomics Lab, Bioinformatics, etc.) provide services to UNC researchers and external clients on a fee-for-service basis, subsidized for UNC Lineberger members. Services include genomic sequencing, cell line repositories, imaging, and analytical support.

unclineberger.org
5Rapid Case Ascertainment Fees
TypeTransaction Fee
Description

RCA charges fees on a fee-for-service basis for facilitating cancer prevention and control research requiring early patient contact through the North Carolina Central Cancer Registry.

unclineberger.org
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Infrastructure
Pricing details2 tiers
1Translational Genomics Lab service rates for UNC investigators
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

DNA/RNA extraction: $35/sample; Dual DNA+RNA extraction: $70/sample; Cell free DNA/RNA extraction: $70/sample; DNA QC/RNA QC: $15/sample; DNA Whole Genome Library Prep: $70/sample; mRNA Library Prep: $120/sample; Total RNA Library Prep: $170/sample; Sequencing: $700-$5,700 per flow cell depending on platform and kit. Rates are subsidized by UCRF and same for all UNC investigators regardless of Lineberger member status.

unclineberger.org
2Patient care and clinical trial services
ModelOtherBilling cadencePay-as-you-go
Notes

Patient appointments available at 1-866-869-1856. Clinical trial participation is free for patients; costs covered by research grants or sponsors. PRO tools are provided at no cost to patients.

unclineberger.org
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

UNC Lineberger is an NCI-designated Comprehensive Cancer Center that conducts basic, translational, and clinical cancer research, delivers multidisciplinary cancer patient care through affiliated clinical facilities, trains the next generation of cancer researchers and clinicians, and operates shared research resources and population health tools. [Inferred from entity name and standard NCI cancer center mission]

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Patient-reported outcome tools improved clinicians' awareness of patient symptoms and accelerated care, leading to better symptom control, improved quality of life, fewer hospitalizations, and longer survival for cancer patients
+4 more records
Product overview1 text field

UNC Lineberger Comprehensive Cancer Center is North Carolina's only public, NCI-designated comprehensive cancer center offering a comprehensive portfolio of cancer research, clinical care, and educational services. The center operates multiple interconnected core facilities and programs including the Translational Genomics Lab (providing genomic sequencing and profiling), Tissue Culture Facility (providing cell lines and reagents), and Rapid Case Ascertainment (enabling early patient recruitment for cancer research). Additional key services include the Clinical Trials Office for operationalizing clinical trials, MaTRIC for population science research project management, Cancer Registry for cancer surveillance data, and the CRTEC training program. The center has developed Patient-Reported Outcomes electronic tools now integrated into Epic EHR systems. Shared Resources span Animal Models, Basic Sciences, Clinical/Translational, Genomics/Proteomics, Population Sciences, and Research Support cores serving the research community.

Product and service7 records
1Cancer Clinical Trials Program
CategoryClinical Research Services
Description

Conducts investigator-initiated and cooperative-group oncology clinical trials for cancer patients across multiple disease sites.

2Translational Genomics Lab
CategoryResearch Core Services
Description

Shared resource providing next-generation sequencing and molecular profiling services for cancer researchers.

3Tissue Culture Facility
CategoryResearch Core Services
Description

Shared resource providing cell culture, hybridoma, and monoclonal antibody production services for cancer investigators.

4Rapid Case Ascertainment (RCA)
CategoryResearch Support Services
Description

Service that rapidly identifies and recruits eligible cancer patients into research studies using the UNC Cancer Registry.

5Cancer Information & Population Health Resource (CIPHR)
CategoryPopulation Health Research
Description

Resource linking cancer registry data with administrative, claims, and clinical data for population-based cancer outcomes research.

6UNC Cancer Registry
CategoryPopulation Health Research
Description

Central cancer registry covering North Carolina that collects and manages cancer incidence data for surveillance and research.

7Cancer Research Training & Education Coordination (CRTEC)
CategoryEducation and Training
Description

Coordinates cancer-relevant training programs for students, postdoctoral fellows, and early-career investigators.

Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

UNC Lineberger received a 2026 Bayer Community Innovation Grant from ZERO Prostate Cancer to expand prostate cancer screening in rural North Carolina through the Check & Protect: UNC Prostate Cancer Awareness and Screening Initiative. This community-based pilot program aims to expand education, screening, and early detection among men at increased risk. UNC Lineberger was one of only five organizations nationwide selected.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Awarded $40,000 Maia James Sarcoma Innovation Grant to Pengda Liu for developing novel antibody-drug conjugates to facilitate clinical translation of new targeted therapies for sarcoma.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

UNC Department of Urology and UNC Lineberger provided clinical leadership for statewide prostate cancer awareness initiatives, supporting PHEN-organized rallies and community health events focused on education, awareness, and early detection across North Carolina.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Community health center partner that launched 'Mega Day' events bringing cancer screening services together in family-friendly, convenient locations close to where patients live, improving access to preventive health services.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnered with UNC Lineberger Community Outreach and Engagement office to host Health and Wellness Fairs offering cancer education, prostate cancer screenings, and preventive health resources to nearly 50 community members.

6North Carolina Central Cancer Registry (CCR)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

RCA is a collaboration between UNC Lineberger, the North Carolina Central Cancer Registry, and participating hospitals. CCR accelerates reporting for quick identification of cancer patients throughout the state, enabling early patient contact for prevention and control research.

unclineberger.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

UNC Lineberger partners with ASCO as part of the OncoPRO national initiative to provide health systems with training, patient education materials, and technical support for implementing PRO tools in cancer care.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner in OncoPRO initiative alongside ASCO to implement patient-reported outcome tools across US health systems, improving symptom tracking and cancer care outcomes.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

More than 20 health systems across the US, including UNC Health, East Carolina University, Wake Forest University, and Duke University, are implementing PRO tools through the OncoPRO initiative led by UNC Lineberger.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

UNC Health is the affiliated health system providing inpatient and outpatient cancer treatment services. UNC Lineberger is the cancer center embedded within UNC School of Medicine, with patient care delivered through UNC Health facilities.

Strategic tierCoreTypeTechnology or Integration
Description

Patient-reported outcome tools developed by UNC Lineberger are now integrated into Epic electronic health record systems and available for use by health systems across the United States and Europe.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center at Duke University, also located in North Carolina's Research Triangle. Directly comparable as an academic comprehensive cancer center delivering oncology research, clinical trials, and patient care in the same geographic market.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center at Atrium Health Wake Forest Baptist. Peer academic cancer center competing for the same North Carolina patient population, faculty, and pharma-sponsored trials.

3UNC Lineberger Cancer Network affiliate cancer centers (e.g., East Carolina University, Coastal Carolina)
TypeRegional player
Description

Regional oncology partners across North Carolina that coordinate cancer care and clinical trial access through the UNC Lineberger Cancer Network, extending the center's reach to underserved communities.

TypeBroad incumbent
Description

The largest NCI-designated Comprehensive Cancer Center in the US, operating at a much larger scale. Comparable in NCI designation, research breadth, and clinical-trial volume, but far larger and more national in reach.

TypeBroad incumbent
Description

NCI-designated Comprehensive Cancer Center with deep translational research, genomic profiling, and clinical trial capabilities. Comparable scope of basic, translational, and clinical oncology research, though at substantially larger scale.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center in the Southeast US. Comparable as an academic cancer center with research programs, shared resources, clinical trials, and community outreach in a similar regional academic setting.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center at Vanderbilt University Medical Center. Compares closely in research program structure, translational genomics, clinical trial infrastructure, and academic medical center affiliation.

TypeBroad incumbent
Description

NCI-designated Comprehensive Cancer Center with extensive translational genomics, clinical trials, and research programs. Comparable research breadth but operates at a substantially larger national scale.

TypeBroad incumbent
Description

NCI-designated Comprehensive Cancer Center with strong translational science, clinical trial infrastructure, and population-based research. Comparable research scope and NCI designation, though with a different structural affiliation (independent research center).

TypeBroad incumbent
Description

NCI-designated Comprehensive Cancer Center combining translational research, precision oncology, and clinical trials within a major academic medical center. Comparable in NCI designation and research breadth, but anchored in a different regional market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

UNC Lineberger

Cancer Research and Treatmentunclineberger.org

UNC Lineberger Comprehensive Cancer Center is North Carolina's only public NCI-designated comprehensive cancer center, conducting translational genomics, clinical trials, population science, and community outreach research while delivering cancer care through UNC Health and serving patients, researchers, and communities statewide.

What UNC Lineberger does

UNC Lineberger Comprehensive Cancer Center, founded in 1972, is North Carolina's only public NCI-designated comprehensive cancer center, operating as an integral component of the University of North Carolina at Chapel Hill School of Medicine and affiliated with UNC Health. It functions as a research, clinical care, and training institution serving cancer patients, researchers, and communities across North Carolina. Its service portfolio spans eight research programs, three Centers of Excellence (bladder, endometrial, pancreatic cancer), and more than 20 center initiatives. Funding flows predominantly from the NCI Cancer Center Support Grant (P30 CA016086), the state-funded University Cancer Research Fund, NIH training grants, and sponsored research agreements; revenue from clinical trial management and core facility fee-for-service represents a secondary stream.

Its core technology and service infrastructure comprises shared resources organized into Animal Models, Basic Sciences, Clinical/Translational, Genomics/Proteomics, Population Sciences, and Research Support cores. Key facilities include the Translational Genomics Lab (high-throughput nucleic acid extraction, NGS library preparation, and sequencing at 20,000+ sample scale), the Tissue Culture Facility (400+ cell line repository), Rapid Case Ascertainment (statewide NC Cancer Registry interface supporting 900+ publications), and the MaTRIC project management platform launched in 2022 for population science research. Proprietary assets include the UNCseq targeted DNA sequencing panel and electronic patient-reported outcomes tools integrated into Epic EHR systems and used in global clinical trials. The center's clinical research infrastructure is operationalized through the Clinical Trials Office supporting investigator-initiated and industry-sponsored trials across breast, lung, prostate, sarcoma, and other oncology indications.

Its go-to-market model is sales-led via clinical referrals and community outreach, complemented by academic convening functions. Patient care is delivered through UNC Health facilities across North Carolina, extended statewide through the UNC Lineberger Cancer Network (telemedicine and community physician partnerships). Research services are sold fee-for-service to UNC investigators (subsidized) and external clients, while genomic and bioinformatic tools scale nationally via Epic integration and the OncoPRO initiative (with ASCO and the American Cancer Society) across 20+ health systems. Customer segments are hybrid: cancer patients (clinical care), academic and clinician-scientists (shared resources, training), referring physicians and health systems (specialty referrals and tool adoption), and rural/underserved NC communities (screening and outreach partnerships with organizations such as Kintegra Health and Raleigh Housing Authority).

UNC Lineberger firmographics

Firmographics
Name
UNC Lineberger
Legal name
UNC Lineberger Comprehensive Cancer Center
Website
https://unclineberger.org
Company type
Private
Founded year
1972
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
UNC Lineberger Comprehensive Cancer Center is North Carolina's only public NCI-designated comprehensive cancer center, conducting translational genomics, clinical trials, population science, and community outreach research while delivering cancer care through UNC Health and serving patients, researchers, and communities statewide.
Ownership category
akta.pro rank

UNC Lineberger industry classification

Industry
Product category
Cancer Research and Treatment
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Diagnostic Imaging Centers (621512), Colleges, Universities, and Professional Schools (611310)
SIC
Services-Medical Laboratories (8071), Services-Health Services (8000), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro primary industry
Oncology & Cancer Specialty Hospitals (HLAFAHAC)
akta.pro secondary industries
Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Central Laboratory Services (Core Lab Operations) (HLAGAEAA), Surgical Oncology (HLAKAFAG)

Keywords

  • Cancer research
  • Clinical oncology
  • Translational research
  • Clinical trials
  • Genomic sequencing

Where UNC Lineberger is headquartered

Location

Headquarters

HQ city
Chapel Hill
HQ country
United States
HQ region
North America

Offices4 records

Markets served

UNC Lineberger business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

  1. Government Research Grants and NCI Funding: UNC Lineberger is an NCI-designated comprehensive cancer center supported by NCI Cancer Center Support Grant P30 CA016086, NIH-funded training grants (T32), and other peer-reviewed cancer-focused research grants. Membership is subject to NCI review and is largely provided to investigators holding NCI or other NIH funding.
  2. University Cancer Research Fund (UCRF): State-funded cancer research investment created by the N.C. General Assembly in 2007. Began with $25 million in 2007 and grew to $59.5 million by 2022. Funds discovery, innovation, and delivery of improved cancer care across North Carolina.
  3. Clinical Trial Revenue: UNC Lineberger's Clinical Trials Office turns research concepts into operational clinical trials, supporting investigator-initiated and industry-sponsored trials. Revenue is generated through clinical research management services, per-trial accruals, and industry sponsorship agreements.
  4. Shared Resource Service Fees: Core facilities (Tissue Culture, Translational Genomics Lab, Bioinformatics, etc.) provide services to UNC researchers and external clients on a fee-for-service basis, subsidized for UNC Lineberger members. Services include genomic sequencing, cell line repositories, imaging, and analytical support.
  5. Rapid Case Ascertainment Fees: RCA charges fees on a fee-for-service basis for facilitating cancer prevention and control research requiring early patient contact through the North Carolina Central Cancer Registry.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goTranslational Genomics Lab service rates for UNC investigators
OtherPay-as-you-goPatient care and clinical trial services

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

UNC Lineberger product offering

Product offering

Core offering

UNC Lineberger is an NCI-designated Comprehensive Cancer Center that conducts basic, translational, and clinical cancer research, delivers multidisciplinary cancer patient care through affiliated clinical facilities, trains the next generation of cancer researchers and clinicians, and operates shared research resources and population health tools. [Inferred from entity name and standard NCI cancer center mission]

Product overview

UNC Lineberger Comprehensive Cancer Center is North Carolina's only public, NCI-designated comprehensive cancer center offering a comprehensive portfolio of cancer research, clinical care, and educational services. The center operates multiple interconnected core facilities and programs including the Translational Genomics Lab (providing genomic sequencing and profiling), Tissue Culture Facility (providing cell lines and reagents), and Rapid Case Ascertainment (enabling early patient recruitment for cancer research). Additional key services include the Clinical Trials Office for operationalizing clinical trials, MaTRIC for population science research project management, Cancer Registry for cancer surveillance data, and the CRTEC training program. The center has developed Patient-Reported Outcomes electronic tools now integrated into Epic EHR systems. Shared Resources span Animal Models, Basic Sciences, Clinical/Translational, Genomics/Proteomics, Population Sciences, and Research Support cores serving the research community.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cancer Clinical Trials Program Conducts investigator-initiated and cooperative-group oncology clinical trials for cancer patients across multiple disease sites.
  • Translational Genomics Lab Shared resource providing next-generation sequencing and molecular profiling services for cancer researchers.
  • Tissue Culture Facility Shared resource providing cell culture, hybridoma, and monoclonal antibody production services for cancer investigators.
  • Rapid Case Ascertainment (RCA) Service that rapidly identifies and recruits eligible cancer patients into research studies using the UNC Cancer Registry.
  • Cancer Information & Population Health Resource (CIPHR) Resource linking cancer registry data with administrative, claims, and clinical data for population-based cancer outcomes research.
  • UNC Cancer Registry Central cancer registry covering North Carolina that collects and manages cancer incidence data for surveillance and research.
  • Cancer Research Training & Education Coordination (CRTEC) Coordinates cancer-relevant training programs for students, postdoctoral fellows, and early-career investigators.

Quantifiable outcome

  • Patient-reported outcome tools improved clinicians' awareness of patient symptoms and accelerated care, leading to better symptom control, improved quality of life, fewer hospitalizations, and longer survival for cancer patients
  • +4 more outcomes

Companies that use UNC Lineberger

Customer profile

Named customers7 records

Segments4 records

Ideal customer profiles2 records

UNC Lineberger technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability5 records

Feature6 records

UNC Lineberger partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • ZERO Prostate CancercoreStrategic or Co-development Partner · 1 January 2026UNC Lineberger received a 2026 Bayer Community Innovation Grant from ZERO Prostate Cancer to expand prostate cancer screening in rural North Carolina through the Check & Protect: UNC Prostate Cancer Awareness and Screening Initiative. This community-based pilot program aims to expand education, screening, and early detection among men at increased risk. UNC Lineberger was one of only five organizations nationwide selected.
  • Strides for Sarcoma FoundationcoreStrategic or Co-development PartnerAwarded $40,000 Maia James Sarcoma Innovation Grant to Pengda Liu for developing novel antibody-drug conjugates to facilitate clinical translation of new targeted therapies for sarcoma.
  • Prostate Health Education Network (PHEN)coreStrategic or Co-development PartnerUNC Department of Urology and UNC Lineberger provided clinical leadership for statewide prostate cancer awareness initiatives, supporting PHEN-organized rallies and community health events focused on education, awareness, and early detection across North Carolina.
  • Kintegra HealthcoreStrategic or Co-development PartnerCommunity health center partner that launched 'Mega Day' events bringing cancer screening services together in family-friendly, convenient locations close to where patients live, improving access to preventive health services.
  • Raleigh Housing AuthorityminorStrategic or Co-development PartnerPartnered with UNC Lineberger Community Outreach and Engagement office to host Health and Wellness Fairs offering cancer education, prostate cancer screenings, and preventive health resources to nearly 50 community members.
  • North Carolina Central Cancer Registry (CCR)coreStrategic or Co-development PartnerRCA is a collaboration between UNC Lineberger, the North Carolina Central Cancer Registry, and participating hospitals. CCR accelerates reporting for quick identification of cancer patients throughout the state, enabling early patient contact for prevention and control research.
  • American Society of Clinical Oncology (ASCO)coreStrategic or Co-development PartnerUNC Lineberger partners with ASCO as part of the OncoPRO national initiative to provide health systems with training, patient education materials, and technical support for implementing PRO tools in cancer care.
  • American Cancer SocietycoreStrategic or Co-development PartnerPartner in OncoPRO initiative alongside ASCO to implement patient-reported outcome tools across US health systems, improving symptom tracking and cancer care outcomes.
  • OncoPRO Participating Health SystemscoreStrategic or Co-development PartnerMore than 20 health systems across the US, including UNC Health, East Carolina University, Wake Forest University, and Duke University, are implementing PRO tools through the OncoPRO initiative led by UNC Lineberger.
  • UNC HealthcoreStrategic or Co-development PartnerUNC Health is the affiliated health system providing inpatient and outpatient cancer treatment services. UNC Lineberger is the cancer center embedded within UNC School of Medicine, with patient care delivered through UNC Health facilities.
  • Epic SystemscoreTechnology or IntegrationPatient-reported outcome tools developed by UNC Lineberger are now integrated into Epic electronic health record systems and available for use by health systems across the United States and Europe.

Scale indicators14 records

Recent moves6 records

Expansion highlights6 records

UNC Lineberger competitors and assessment

Company assessment

Direct peers

  • Duke Cancer Institute: NCI-designated Comprehensive Cancer Center at Duke University, also located in North Carolina's Research Triangle. Directly comparable as an academic comprehensive cancer center delivering oncology research, clinical trials, and patient care in the same geographic market.
  • Wake Forest Baptist Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center at Atrium Health Wake Forest Baptist. Peer academic cancer center competing for the same North Carolina patient population, faculty, and pharma-sponsored trials.
  • Winship Cancer Institute of Emory University: NCI-designated Comprehensive Cancer Center in the Southeast US. Comparable as an academic cancer center with research programs, shared resources, clinical trials, and community outreach in a similar regional academic setting.
  • Vanderbilt-Ingram Cancer Center: NCI-designated Comprehensive Cancer Center at Vanderbilt University Medical Center. Compares closely in research program structure, translational genomics, clinical trial infrastructure, and academic medical center affiliation.

Regional players

  • UNC Lineberger Cancer Network affiliate cancer centers (e.g., East Carolina University, Coastal Carolina): Regional oncology partners across North Carolina that coordinate cancer care and clinical trial access through the UNC Lineberger Cancer Network, extending the center's reach to underserved communities.

Broad incumbents

  • MD Anderson Cancer Center: The largest NCI-designated Comprehensive Cancer Center in the US, operating at a much larger scale. Comparable in NCI designation, research breadth, and clinical-trial volume, but far larger and more national in reach.
  • Memorial Sloan Kettering Cancer Center: NCI-designated Comprehensive Cancer Center with deep translational research, genomic profiling, and clinical trial capabilities. Comparable scope of basic, translational, and clinical oncology research, though at substantially larger scale.
  • Sidney Kimmel Cancer Center (Johns Hopkins): NCI-designated Comprehensive Cancer Center with extensive translational genomics, clinical trials, and research programs. Comparable research breadth but operates at a substantially larger national scale.
  • Fred Hutchinson Cancer Center: NCI-designated Comprehensive Cancer Center with strong translational science, clinical trial infrastructure, and population-based research. Comparable research scope and NCI designation, though with a different structural affiliation (independent research center).
  • UCSF Helen Diller Family Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center combining translational research, precision oncology, and clinical trials within a major academic medical center. Comparable in NCI designation and research breadth, but anchored in a different regional market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

UNC Lineberger social profiles

Digital presence

UNC Lineberger compliance and trust

Trust signal

Compliance1 record

UNC Lineberger financial estimates

Financial estimate

Revenue estimate

Valuation estimate

UNC Lineberger leadership team

Management profile

Number of profiles

Profiles1 record

UNC Lineberger funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

UNC Lineberger M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UNC Lineberger

What does UNC Lineberger do?

UNC Lineberger is an NCI-designated Comprehensive Cancer Center that conducts basic, translational, and clinical cancer research, delivers multidisciplinary cancer patient care through affiliated clinical facilities, trains the next generation of cancer researchers and clinicians, and operates shared research resources and population health tools. [Inferred from entity name and standard NCI cancer center mission]

Is UNC Lineberger a public or private company?

UNC Lineberger is a private company. It is classified as state government owned and is currently operating.

When was UNC Lineberger founded?

UNC Lineberger was founded in 1972. It employs 1,001 to 5,000 people.

Where is UNC Lineberger based?

UNC Lineberger is headquartered in Chapel Hill, United States, in the North America region.

How does UNC Lineberger make money?

Five revenue lines are on record. Government Research Grants and NCI Funding is the primary driver. The others are university Cancer Research Fund (UCRF), clinical Trial Revenue, shared Resource Service Fees and rapid Case Ascertainment Fees.

Who are UNC Lineberger's main competitors?

Direct peers on record are Duke Cancer Institute, Wake Forest Baptist Comprehensive Cancer Center, Winship Cancer Institute of Emory University and Vanderbilt-Ingram Cancer Center. UNC Lineberger Cancer Network affiliate cancer centers (e.g., East Carolina University, Coastal Carolina) is listed as a regional player. Broad incumbents are MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Sidney Kimmel Cancer Center (Johns Hopkins), Fred Hutchinson Cancer Center and UCSF Helen Diller Family Comprehensive Cancer Center.

Does UNC Lineberger have an API?

No public API is recorded for UNC Lineberger.

What industry is UNC Lineberger in?

UNC Lineberger's product category is Cancer Research and Treatment. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 622310 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mirage NewsUNC Advances Prostate Cancer Care Beyond PSA TestingUNC Lineberger Comprehensive Cancer Center combines PSA screening with MRI and MRI-guided biopsies to target prostate cancer more precisely. The center also uses PSMA-targeted radiopharmaceutical therapy, including the FDA-approved lutetium Lu 177 vipivotide tetraxetan, for metastatic disease. Dr. Pepin and colleagues are expanding these multidisciplinary programs.American City Business JournalsUNC gets $40M OpenAI grant for personalized cancer vaccinesUNC received a $40M OpenAI grant for a four-year project to generate datasets and run clinical trials comparing vaccine platforms. Most data will be made publicly available to researchers worldwide.BeckershospitalreviewOpenAI gives UNC cancer center $40M to fuel cancer vaccine developmentOpenAI's foundation gave $40 million to UNC Lineberger Comprehensive Cancer Center to generate data for personalized cancer vaccines. Researchers will train AI models on tumor and immune cell data and conduct clinical trials for triple-negative breast cancer. The grant is part of a $125 million Public Data for Health program.News-MedicalUNC researcher wins major grant to study the role of endoplasmic reticulum in T-cell metabolismUNC researcher Jessica Thaxton received a $700,000 Mathers Foundation grant to study the endoplasmic reticulum's role in T-cell metabolism and cancer. The award is the first to a UNC-Chapel Hill faculty member in 20 years. Her project will explore whether adjusting ER structure can help immune cells better destroy tumors.Mirage NewsThaxton Wins Prestigious Grant for T-Cell ResearchJessica Thaxton, PhD, associate professor in the Department of Cell Biology and Physiology at UNC School of Medicine and co-leader of the Cancer Cell Biology Research Program at UNC Lineberger Comprehensive Cancer Center, received a $700,000 grant from the G. Harold & Leila Y. Mathers Foundation. The award, the first to a UNC-Chapel Hill faculty member in two decades, funds research on endoplasmic reticulum architecture and T-cell metabolism in cancer.Mirage NewsUNC, OHSU Secure $4M to Tackle Cancer Screening BarriersResearchers at UNC Lineberger Comprehensive Cancer Center and Oregon Health & Science University received a $4 million, six-year multi-phase UG3/UH3 award from the National Cancer Institute to bundle outreach for multiple cancer screenings at safety-net clinics in North Carolina and Oregon. The project, led by Wheeler, Brenner and Davis, will use mailed screening kits, population reminders and patient navigation, aiming to raise cervical, colorectal and mammography screening rates.Mirage NewsCould One Blood Test Detect Multiple Cancers Earlier?Researchers at UNC Lineberger Comprehensive Cancer Center are recruiting participants for the Vanguard Study, which evaluates a multi-cancer detection assay (MCD) capable of screening for ten types of cancer via a single blood test. The study aims to compile data for the National Cancer Institute by enrolling adults aged 45 to 75 who have not been diagnosed with cancer in the past five years.Newsroom“Data for Everyone”: A New Cancer Dashboard Launches at UNC Lineberger Comprehensive Cancer CenterUNC Lineberger Comprehensive Cancer Center has launched the North Carolina Cancer Health Assets and Needs Assessment (CHANA), a public data dashboard that aggregates cancer-related health data from multiple sources including the North Carolina Central Cancer Registry, the CDC, and community surveys. The tool, funded by the University Cancer Research Fund, is designed to help researchers, healthcare providers, and policymakers monitor cancer incidence, screening, risk factors, and treatment trends across all 100 counties in North Carolina. CHANA includes online dashboards, a 112-page report for decision-makers, and county-level profiles for community distribution.UnclinebergerAdvanced Cellular Therapeutics FacilityThe Advanced Cellular Therapeutics (ACT) Facility, established in 2015 at UNC Lineberger Comprehensive Cancer Center, manufactures clinical-grade cellular therapy products and retroviral vectors for cancer treatment. The facility operates under cGMP/cGTP standards to prepare, test, and release these products while minimizing delivery times through its proximity to the University of North Carolina at Chapel Hill. This infrastructure supports adoptive cell therapy trials by providing necessary regulatory-compliant manufacturing capabilities.PR NewswireFormer patient donates $10 million to further blood cancer research at UNC LinebergerChamp and ET Mitchell of New Bern, North Carolina, have made a $10 million donation to UNC Lineberger Comprehensive Cancer Center to create the Champ and ET Mitchell Fund for Blood Cancer Research, supporting research into lymphoma, leukemia, and myeloma. Champ Mitchell, a two-time UNC-Chapel Hill alumnus and former patient, was treated for stage 4 Non-Hodgkin's Lymphoma at the North Carolina Cancer Hospital and credits Dr. Thomas C. Shea's team for his recovery. The gift is the largest single donation to UNC Lineberger in recent years and will accelerate cellular immunotherapy research and clinical trials at the center.